Objective: Sepsis is life-threatening organ dysfunction due to dysregulated host responses to infection. Current knowledge of human B-cell alterations in sepsis is sparse. We tested the hypothesis that B-cell loss in sepsis involves distinct subpopulations of B cells and investigated mechanisms of B-cell depletion. 9 cells/L) and selective depletion of memory B cells despite normal B cell survival ligand concentrations. Greater apoptotic depletion of class-switched and IgM memory cells was associated with phosphorylation of extracellular signal-regulated kinases, implying externally driven lymphocyte stress and activation-associated cell death. This inference is supported by gene expression profiles highlighting mitochondrial dysfunction and cell death pathways, with enriched intrinsic and extrinsic pathway apoptosis genes. Conclusions: Depletion of the memory B-cell compartment contributes to the immunosuppression induced by sepsis. Therapies targeted at reversing this immune memory depletion warrant further investigation. (Crit Care Med 2017; 45:875-882) 
survivors well beyond their hospital discharge (6) , and likely contribute to infection-related readmissions (7) (8) (9) (10) (11) , worsening comorbidities, and worse long-term outcomes (12) .
Both loss and decreased functionality of lymphocytes contribute to this immunosuppressed state (2, 3, 13) . Secondary lymphoid organs taken from septic patients have lower cellular density when compared with healthy controls, with loss of antigen-presenting cells and T-cell exhaustion that may impair B-cell maturation (3, 13, 14) . Murine sepsis models identify early B-cell activation by type-1 interferon yet despite depletion of the naive mantle zone B-cell compartment, peripheral B-cell maturation progresses unhindered (15) . B cells have both antibodydependent and independent functions in such sepsis models. For example, impaired cytokine production and reduced survival in recombination-activating gene deficient (RAG1 -/-) septic mice could be replicated in wild-type models after depletion of B cells using anti-CD20 antibodies. Survival rates increased in these RAG1
-/-mice when treated with either serum or with B cells from wild-type mice (15) . In other models using chimeric and knockout mice, a novel B-cell effector subset was identified that secretes granulocyte-monocyte colony-stimulating factor, reduces illness severity by altering cytokine profiles, enhances pathogen clearance, and improves sepsis outcomes (16) .
Current knowledge of human B cells in sepsis is sparse, discordant, and at variance with findings reported from animal models. Descriptions of sepsis-related abnormalities in the B-cell compartment are limited to inconsistent reports of changes in absolute counts, in activation status (17) (18) (19) (20) , and immunoglobulin levels (21) . Optimal management of patients with sepsis requires a clear understanding of the potential for manipulation of the humoral response and how the B-cell compartment could support healthy life after recovery. We tested the hypothesis that B-cell loss in sepsis involves distinct subpopulations of B cells and investigated the mechanisms of B-cell depletion.
MATERIALS AND METHODS

Study Design and Setting
This prospective observational cohort study was performed in the general medical-surgical critical care units of a university hospital. Ethics committee approval was obtained prior to start of recruitment (10/H0807/81 and 12/LO/0326; Camberwell St Giles Committee, United Kingdom). Clinical management was at the discretion of the attending physicians. Informed consent was obtained from patients or, where they lacked competency, from personal legal representatives. Retrospective consent was sought from patients after they regained mental competency.
Study Population
Consecutive patients with sepsis (before severe sepsis/septic shock [22] ) within the first 12 hours following ICU admission between May 2011 and January 2015 were included. Sepsis was defined as evidence of two or more systemic inflammatory response syndrome criteria, with proven or suspected infection and at least one organ system dysfunction (cardiovascular, respiratory, renal, hematologic, or metabolic) (22) . Exclusion criteria included patients less than 18 years old, those with congenital hypogammaglobulinemia; known protein-losing enteropathies; nephrotic syndrome; neoplastic or proliferative hematologic diseases; those having received IV immunoglobulin therapy in the last 3 months; those receiving high-dose corticosteroid therapy; on-going blood loss (defined by blood transfusion requirement > 2 U/24-hr period); retroviral disease; and immune dysfunction as defined by Acute Physiology and Chronic Health Evaluation (APACHE) II score comorbidities (23) .
Clinical Data and Blood Sampling
Baseline demographic data, daily laboratory results, daily worst physiologic variables, and the APACHE II (23) and the Sepsis-related Organ Failure Assessment (SOFA) scores (24) were obtained from the clinical information systems (CareVue; Philips, Guildford, United Kingdom; and electronic patient records). Fresh blood samples for all experiments were collected daily from admission day until day 7 following ICU admission, if sooner on the day of demise or discharge (defined as final measurement [DF] ).
Flow Cytometry
For isolating peripheral blood mononuclear cells (PBMCs) and for whole blood flow cytometry, EDTA anticoagulated blood was collected. All anti-human fluorochromes were from Becton Dickinson and Company (BD) (Franklin Lakes, NJ) unless otherwise specified. For each target molecule, the fluorochrome and clone used are reported in parenthesis. For all experiments, AmCyan (L34957; Invitrogen; Thermo Fisher Scientific, Waltham, MA) was used to identify alive cells. To estimate the absolute B-cell counts in sepsis patients, whole blood (50 μL) and beads were labeled for 20 minutes at room temperature using CD19 (PE; LT19), CD45 (PeCY7; H130), and CD69 (FITC; FN50) antibody combinations and the corresponding isotype controls and estimated using flow cytometry on Canto-A flow cytometer (BD) using Diva Software Version 6.1 (BD) following RBC lysis. Admission day and DF absolute B-cell counts are reported.
For all other experiments, PBMCs were isolated within 4 hours of blood sampling using Ficoll density centrifugation and stored in liquid nitrogen as viable cells for future analysis. To identify B-cell subsets, we used the following: anti-CD19 (PerCP Cy5.5; HB19); anti-CD24 (PeCyTM7; ML5); anti-CD27 (APC; MT271); anti-CD38 (PE; HIT2; eBioscience, Hatfield, United Kingdom); anti-IgM (V450; G20-127); anti-IgA (FITC; IS11-8E10; Miltenyi); anti-IgG (APCH7; G18-145); annexin-V (PeCyTM7; eBioscience); anti-CD27 (FITC; O323; eBioscience); anti-phosphorylated extracellular signal-regulated (P-ERK) (PE; RateK1); anti-p-BTK (Alexafluor674; 24a/BTK); anti-p-SYK (Alexafluor488; human Syk peptide); and anti-p-AKT (APC; eBioscience). Staining for phosphorylation status of intracellular kinases was performed using the BD Cytofix/ Cytoperm kit and phosphoflow buffers as per manufacturer guidelines. Flow cytometer set up and calibration was done for every experiment. Reagents remained the same during the course of the study. Gating during analysis of flow cytometry standard files was achieved using isotype controls, fluorescence minus-one controls, and/or single stain controls. Admission day B-cell subset profiles are reported.
Enzyme-Linked Immunosorbent Assay (ELISA)
Quantitative detection of human B cell-activating factor of the tumor necrosis factor family (BAFF) and a proliferationinducing ligand (A proliferation inducing ligand [APRIL]) in admission day serum in sepsis patients and age-matched healthy controls was done in triplicate using commercial ELISA kits from eBioscience.
Microarray
CD19+ B cells from sepsis and healthy controls were isolated to a purity of greater than 99% using EasySep Positive Selection kit (Stem Cell Technologies, Cambridge, UK). Purity was confirmed with flow cytometry. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Manchester, UK). RNA was converted to complementary DNA (cDNA) using the Ovation Pico WTA Systems V2 and labeled using the Encore BiotinIL Module (Nugen, Leek, The Netherlands). Labeled cDNA was hybridized onto Infinium Illumina HT12v4 arrays and data collected on an iSCAN array scanner (Illumina, Cambridge, UK). Following scanning, basic QC statistics were completed, displaying hybridization controls, background signal, and mean gene intensity of all genes and those of housekeeping genes. Array results were compiled using Genome Studio (Illumina) following quantile normalization. Differences in messenger RNA abundance between the sepsis and healthy controls were assessed using Partek Genomic Suite (Partek, St. Louis, MO). Similarities and differences in cell-specific gene expression pattern in healthy controls and sepsis were assessed using heat maps and the top canonical pathways identified using Ingenuity Pathway Analysis (IPA; Qiagen). Apoptosis genes and pathways were also studied.
Healthy Controls
Every experiment had samples from sepsis patients and contemporaneous healthy controls. Blood was sampled from contemporaneous healthy controls who were consented prior to sampling as per the King's College London Infectious Diseases Biobank protocol (25) and used for ELISA assays (n = 13), flow cytometry (n = 48), and microarrays (n = 6) experiments. The control individuals were age and gender frequency matched to within 5 years of the sepsis samples. Aside from mean fluorescent intensity (MFI) comparisons by apoptosis status within sepsis, all other comparisons were done between healthy controls and sepsis.
Statistics
Continuous data are presented as mean and sd when normally distributed and as median and interquartile range (IQR) when not. Frequency and percentages are presented for categorical data. Statistical tests included unpaired or paired t tests or the corresponding nonparametric equivalents where appropriate accounting for unequal variances. All analyses were performed using GraphPad Prism version 6.00 (GraphPad Software, La Jolla, CA) and Stata/SE Version 13.0 (StataCorp LP, College Station, TX). Reported p values are two sided with p values less than 0.05 representing a statistically significant result.
RESULTS
Study Cohort
Mean (sd) age was 64.8 (13.7) years, and 62.4% were male. The respiratory tract was the most common infection site (64.4%), followed by intra-abdominal (15.0%), wound, bone, and soft tissues (11.0%), and urinary tract (6.9%). The mean (sd) APACHE II score was 19.5 (5.7), and the median (IQR) SOFA score was 7 (6-9). Acute hospital mortality was 26.7% (eTable 1, Supplemental Digital Content 1, http://links.lww.com/CCM/C455).
Sepsis Patients Have a High Prevalence of
Lymphopenia, Low Absolute B-Cell Counts, and Normal B Cell-Specific Survival Factor Concentrations Lymphopenia was defined as an absolute lymphocyte count less than 1.2 × 10 9 cells/L. Persistent and more severe lymphopenia was observed in nonsurvivors compared to survivors over the first 7 days of ICU stay (p < 0.001 on days 2, 3, 4, and 5; comparing absolute lymphocyte counts) ( Fig. 1A ; eFig. 1, Supplemental Digital Content 1, http://links.lww.com/CCM/ C455). Sequential investigations were performed to test the study hypothesis that used samples from randomly selected sepsis patients and matched controls. To permit this range of detailed investigations, all 101 sepsis patient samples were not used for all parts of the study reported in this article.
On admission day, the median (IQR) B-cell count was 0.133 (0.093-0.277) 10 9 cells/L, and there were no statistically significant differences in B-cell counts between admission day and DF (p = 0.23) in sepsis (Fig. 1B) ; subsequent experiments were performed using admission day samples in sepsis. There were no differences between sepsis patients and healthy controls in the serum levels of B cell-specific survival factors (BAFF: Fig. 1C; APRIL: Fig. 1D ).
Sepsis-Associated B-Cell Depletion Is Most Severe in
Memory B-Cell Subsets B-cell subsets were quantified by flow cytometry as the proportion of live CD19 cells in PBMCs. The gating strategy is shown in eFigure 2 (Supplemental Digital Content 1, http://links. lww.com/CCM/C455). No difference was seen between sepsis patients and healthy controls in the frequency of transitional B-cell subsets (p = 0.70 for T1; p = 0.21 for T2) ( Fig. 2A) and the proportion of naive B cells (Fig. 2B) . In marked contrast, the proportions of plasmablasts, IgM memory B cells, and classswitched memory B cells were all significantly lower (p = 0.002 for plasmablasts; p = 0.0002 for IgM memory; p = 0.001 for IgA memory cells; and p = 0.013 for IgG memory) (Fig. 2, C-F) . Digital Content 1, http://links.lww.com/CCM/C455). B-cell apoptosis was highest in the memory subsets (Fig. 3A) , which were also the B-cell subsets with greatest proportional depletion (Fig. 2, D-F) .
B-Cell Apoptosis in Sepsis Is
Phosphorylation of intracellular kinases such as ERK can be considered as surrogates for intracellular stress signaling (26, 27) . In sepsis patients, the p-ERK MFI was significantly higher in IgM memory (p = 0.0002) and class switch recombination (CSR) memory (p = 0.004) subsets when compared with naive B cells (Fig. 3B, left) . In contrast, this difference was not observed in B cells from healthy subjects (Fig. 3B, right) . In sepsis, annexin-V positive CD19 B cells had significantly higher p-ERK MFI when compared with annexin-V negative cells (p = 0.002) (Fig. 3C) ; these differences were replicated in the B-cell subsets (Fig. 3, D-F) . Reciprocal changes were observed in the CD22 MFI, another key B-cell receptor (BCR) signaling modulator (28) (Fig. 4, A-D) , supporting the hypothesis that B-cell death is a nonrandom event associated with an activated profile. No differences between apoptotic and nonapoptotic B cells were seen in phosphorylation of the more BCR proximal kinases, Bruton's tyrosine kinase (BTK) and spleen tyrosine kinase (SYK) (eFig. 
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DISCUSSION
Changes in the relative proportions of B-cell subsets in critically ill patients with sepsis are reported here for the first time. B-cell depletion is an acute phenomenon as it was observed on admission day samples, with an exaggerated proportional loss of antigen-experienced B-cell subsets, that is, plasmablasts and memory cells. B-cell apoptosis is greater in memory cells when compared with naive B cells, consistent with the finding that these B-cell subsets are the most depleted. This suggests that B-cell depletion is not a consequence of impaired bone marrow production.
The observed cell death events occurred despite normal concentrations of BAFF and APRIL and involve well-characterized, activation-associated apoptosis pathways. In healthy controls, generation of high affinity antibody responses depends on T-cell functionality since it requires B cell: T cell cognate interaction for the generation of germinal center responses (29, 30) . There are well-characterized abnormalities in T-cell effector function in sepsis (3, (31) (32) (33) (34) (35) (36) (37) that may explain the lower frequencies of memory cells and plasmablasts observed. Our data suggest that this depletion is related to a higher susceptibility to death rather than a failure to create them due to a lack of T cell help.
The BCR complex is composed of a cell-surface immunoglobulin molecule noncovalently bound to the antigen-nonspecific signaling protein dimers CD79a and CD79b. BCRs have two main roles, antigen binding and transmitting signals to regulate B-cell fate decisions (28) . BCR crosslinking activates SRC family kinases such as LYN, which phosphorylates the immune tyrosine-based activation moieties (ITAM). Binding of SYK to these double-phosphorylated ITAM moieties activates SYK, which then rapidly phosphorylates the scaffold protein B-cell linker (BLNK). Phospholipase C-gamma 2 is activated secondary to BLNK and BTK interactions, which results in transcription factor activation and activation of downstream ERK1/2 kinases via phosphorylation (38) . Of the three BCR signaling pathway kinases studied, only p-ERK MFI was significantly higher in the more apoptotic IgM and CSR memory B-cell subsets, when compared with naive B cells from the same .77-11.57%) in sepsis compared to 2.76% (1.92-4.52%) in health; p = 0.0007) (A). The class-switched memory B-cell subset showed the greatest extent of apoptosis, which also was the proportionally most deplete B-cell subsets (Fig. 2) . B-F, To ascertain differences in key regulatory and B-cell receptor signaling molecules, after cell surface with CD19, CD27, CD22, IgM, and annexin-V, the cells were fixed and permeabilized followed by intracellular staining for phosphokinases and protein kinase B (AKT) (gating shown in eFig. 3, Supplemental Digital Content 1, http://links.lww.com/CCM/C455). Only paired tests were used to compare the differences within sepsis and within health by apoptosis status to account for experimental differences in MFI, importantly no statistical comparisons between sepsis versus health were conducted. Figure shows the significant differences observed between apoptosis and nonapoptosis B-cell population for phosphorylated ERK (p-ERK) status in sepsis patients (n = 10) compared to health (n = 5). There were significant differences between phosphorylated-AKT, phosphorylated-BTK, and phosphorylated-SYK (eFig. 4, Supplemental Digital Content 1, http://links.lww.com/CCM/C455) status with these comparisons. CSR = class switch recombination, H = healthy controls, p-BTK = phosphorylated BTK, p-ERK = phosphorylated ERK, p-SYK = phosphorylated SYK. subjects, with no evidence for increased phosphorylation of the more BCR proximal kinases BTK and SYK. This implies that on ICU admission day, B cells from sepsis patients are not in the early stages of activation through their BCR. It would be highly unlikely that the memory populations with activated profiles would all have antigenic specificity for the causal infectious agent (39) .
Phosphorylation of ERK can be associated with transition to an apoptotic state (40) (41) (42) . Memory B-cell subsets have different susceptibilities to apoptosis when compared with naive B cells (43) . Determinants of the four potential fates of activated B cells (division, death, differentiation, and class switch) are complex and only predictable with limited certainty (44) . Data presented here suggest that cell death in sepsis is externally driven rather than through the BCR while ERK plays an important role in activation-associated B-cell death in sepsis. The microarray analyses of the B cells identified mitochondrial dysfunction with alterations in ATP5J, ATP50, cytochrome C oxidase subunit 8A, nicotinamide adenine dinucleotide dehydrogenase 1 sub complexes α-1 and β-10 genes, and the serine/glycine super pathways (which included the genes phosphoglycerate dehydrogenase and serine hydroxymethyl transferase 2) dehydrogenase 1 sub complexes α-1 and β-10 genes, and the serine/glycine super pathways (which included the genes PHGDH and SHMT2) (45, 46) . When taken together, these alterations in gene expression also support the concept of activation-associated B-cell death in sepsis (eFig 7, A-C, Supplemental Digital Content 1, http://links.lww.com/CCM/C455).
Immunosuppression is a clinically valuable term used to communicate acute impairment of the immune system in sepsis. This persists beyond the acute illness in sepsis survivors, with a marked reduction in cellularity in the secondary lymphoid organs (3, 13, 47) . Reversing this suppression requires a better understanding of contributory factors during the acute phase, and of factors that maintain this state thereafter. Current paradigms to reverse this sepsis-related immunosuppression focus on interventions such as anti-interleukin-3, interleukin-7, antiprogrammed death ligand-1 antibody, and granulocyte-monocyte colony-stimulating factor aimed at managing excess inflammation and/or acute functional impairment. Two fundamentally different facets to sepsis immunosuppression should perhaps be considered independently: functional (immune dysfunction) and structural abnormalities (immune depletion). The latter is particularly relevant when considering infection-related readmissions in sepsis survivors (7) (8) (9) (10) (11) . We identified that B-cell depletion preferentially affects memory B-cell subsets. This could be due to either impaired secondary lymphoid organ maturation and/or accelerated apoptosis in the peripheral circulation. The relative contributions of these different mechanisms on B-cell subsets require further elucidation. Restoring immune capability thus requires replenishment of B-cell numbers as well as boosting the memory cell pool with antigen challenge to replenish lymphocyte cellularity in secondary lymphoid organs of sepsis survivors.
CONCLUSIONS
We report selective depletion of antigen-experienced B cells in sepsis. Depletion of the memory B-cell compartment contributes to the immunosuppression induced by sepsis. Therapies targeted at reversing this immune depletion state should be actively investigated. Figure 4 . B-cell apoptosis in sepsis was associated with reciprocal lower mean fluorescent intensity (MFI) for CD22 without concomitant higher MFI for Bruton's tyrosine kinase (BTK) and spleen tyrosine kinase (SYK). To ascertain differences in key regulatory and B-cell receptor signaling molecules, after cell surface with CD19, CD27, CD22, immunoglobin M (IgM), and annexin-V, the cells were fixed and permeabilized followed by intracellular staining for phosphokinases and protein kinase B (AKT) (gating shown in eFig. 3, Supplemental Digital Content 1, http://links.lww.com/CCM/C455). Only paired tests were used to compare the differences within sepsis and within health by apoptosis status to account for experimental differences in MFI, importantly no statistical comparisons between sepsis versus health were conducted. A-D shows the significant differences observed between apoptosis and nonapoptosis B-cell population for CD22 status in health samples (n = 7) and sepsis (n = 9). There were significant differences between phosphorylated-AKT, phosphorylated-BTK, and phosphorylated-SYK (eFig. 4, Supplemental Digital Content 1, http://links.lww.com/CCM/C455) status with these comparisons. CSR = class-switch recombination memory cells refers to immunoglobin G and immunoglobin A memory B cells.
